Abstract
Antiviral activity of antisense oligodeoxyribonucleotides with phosphorothioate or mesyl phosphoramidate internucleotidic groups targeting the main capsid protein VP72 mRNA of the African swine fever virus (ASFV), either in a free form with Lipofectamine 3000 transfection or in the form of ionic complexes with amino-modified mesoporous silicon dioxide nanoparticles, has been evaluated in Vero cells infected with ASFV. Relatively high cytotoxicity of oligonucleotide nanocomplexes for Vero cells at concentrations above 500 nM was detected. Two sequences of antisense oligonucleotides were identified, which reduced the virus titer by an order of magnitude at 500 nM. The antiviral effect of nanocomplexes exceeded that of free oligonucleotides in the presence of Lipofectamine 3000, which indicates a more efficient delivery of nanocomplexes to the cells. Antisense oligonucleotides able to reduce the replication of ASFV were hitherto unknown from the literature. The obtained data can be used as a starting point for further research on the development of oligonucleotide-based antiviral drugs against the African swine fever virus.
Similar content being viewed by others
REFERENCES
Costard, S., Mur, L., Lubroth, J., Sanchez-Vizcaino, J.M., and Pfeiffer, D.U., Virus Res., 2013, vol. 173, pp. 191–197. https://doi.org/10.1016/j.virusres.2012.10.030
Penrith, M.-L., Vosloo, W., Jori, F., and Bastos, A.D., Virus Res., 2013, vol. 173, pp. 228–246. https://doi.org/10.1016/j.virusres.2012.10.011
Sánchez-Vizcaíno, J.M., Mur, L., and Martínez-López, B., Vet. Microbiol., 2013, vol. 165, pp. 45–50. https://doi.org/10.1016/j.vetmic.2012.11.030
Cisek, A.A., Dąbrowska, I., Gregorczyk, K.P., and Wyżewski, Z., Ann. Parasitol., 2016, vol. 62, pp. 161–167. https://doi.org/10.17420/ap6203.49
Gogin, A., Gerasimov, V., Malogolovkin, A., and Kolbasov, D., Virus Res., 2013, vol. 173, pp. 198–203. https://doi.org/10.1016/j.virusres.2012.12.007
Oganesyan, A.S., Petrova, O.N., Korennoy, F.I., Bardina, N.S., Gogin, A.E., and Dudnikov, S.A., Virus Res., 2013, vol. 173, pp. 204–211. https://doi.org/10.1016/j.virusres.2012.12.009
Gallardo, M.C., Reoyo, A.T., Fernández-Pinero, J., Iglesias, I., Muñoz, M.J., and Arias, M.L., Porcine Health Manage., 2015, vol. 1, p. 21. https://doi.org/10.1186/s40813-015-0013-y
Zakaryan, H. and Revilla, Y., Vet. Microbiol., 2016, vol. 185, pp. 15–19. https://doi.org/10.1016/j.vetmic.2016.01.016
Stephenson, M.L. and Zamecnik, P.C., Proc. Natl. Acad. Sci. U. S. A., 1978, vol. 75, pp. 285–288. https://doi.org/10.1073/pnas.75.1.285
Uhlmann, E. and Peyman, A., Chem. Rev., 1990, vol. 90, pp. 543–584. https://doi.org/10.1021/cr00102a001
De Mesmaeker, A., Haener, R., Martin, P., and Moser, H.E., Acc. Chem. Res., 1995, vol. 28, pp. 366–374. https://doi.org/10.1021/ar00057a002
Goodchild, J., Methods Mol. Biol., 2011, vol. 764, pp. 1–15. https://doi.org/10.1007/978-1-61779-188-8_1
Perry, C.M. and Balfour, J.A., Drugs, 1999, vol. 57, pp. 375–380. https://doi.org/10.2165/00003495-199957030-00010
Juliano, R.L., Ming, X., and Nakagawa, O., Bioconjug. Chem., 2012, vol. 23, pp. 147–157. https://doi.org/10.1021/bc200377d
Parveen, S., Misra, R., and Sahoo, S.K., Nanomedicine, 2012, vol. 8, pp. 147–166. https://doi.org/10.1016/j.nano.2011.05.016
Design, Synthesis, Multifunctionalization and Biomedical Applications of Multifunctional Mesoporous Silica-Based Drug Delivery Nanosystems, Chen, Y., Ed., Springer, 2016.
Ryabchikova, E.I., Chelobanov, B.P., Parkhomenko, R.G., Korchagina, K.V., and Basova, T.V., Micropor. Mesopor. Mater., 2017, vol. 248, pp. 46–53. https://doi.org/10.1016/j.micromeso.2017.04.006
Miroshnichenko, S.K., Patutina, O.A., Burakova, E.A., Chelobanov, B.P., Fokina, A.A., Vlassov, V.V., Altman, S., Zenkova, M.A., and Stetsenko, D.A., Proc. Natl. Acad. Sci. U. S. A., 2019, vol. 116, pp. 1229–1234. https://doi.org/10.1073/pnas.1813376116
Crooke, S.T., Nucleic Acid Ther., 2017, vol. 27, pp. 70–77. https://doi.org/10.1089/nat.2016.0656
Wagner, A., Bock, C.T., Fechner, H., and Kurreck, J., Future Med. Chem., 2015, vol. 7, pp. 1637–1642. https://doi.org/10.4155/fmc.15.114
Warren, T.K., Shurtleff, A.C., and Bavari, S., Antiviral Res., 2012, vol. 94, pp. 80–88. https://doi.org/10.1016/j.antiviral.2012.02.004
Keita, D., Heath, L., and Albina, E., Antiviral Ther., 2010, vol. 15, pp. 727–736. https://doi.org/10.3851/IMP1593
Vasilyeva, S.V., Grin, I.R., Chelobanov, B.P., and Stetsenko, D.A., Bioorg. Med. Chem. Lett., 2018, vol. 28, pp. 1248–1251. https://doi.org/10.1016/j.bmcl.2018.02.007
Vasilyeva, S.V., Petrova, A.S., Shtil, A.A., and Stetsenko, D.A., J. Saudi Chem. Soc., 2020, vol. 24, pp. 98–104. https://doi.org/10.1016/j.jscs.2019.09.007
Vallet-Regi, M., Rámila, A., del Real, R.P., and Pérez-Pariente, J., Chem. Mater., 2001, vol. 13, pp. 308–311. https://doi.org/10.1021/cm0011559
Castillo, R.R., Colilla, M., and Vallet-Regi, M., Expert. Opin. Drug Delivery, 2017, vol. 14, pp. 229–243. https://doi.org/10.1080/17425247.2016.1211637
Song, Y., Li, Y., Xu, Q., and Liu, Z., Int. J. Nanomed., 2017, vol. 12, pp. 87–110. https://doi.org/10.2147/IJN.S117495
Moreira, A.F., Dias, D.R., and Correia, I.J., Micropor. Mesopor. Mater., 2016, vol. 236, pp. 141–157. https://doi.org/10.1016/j.micromeso.2016.08.038
Xiao, X., Liu, Y., Guo, M., Fei, W., Zheng, H., Zhang, R., Zhang, Y., Wei, Y., Zheng, G., and Li, F., J. Biomater. Appl., 2016, vol. 31, pp. 23–35. https://doi.org/10.1177/0885328216637211
Guo, Y., Sun, J., Bai, S., and Jin, X., J. Biomater. Appl., 2016, vol. 31, pp. 411–420. https://doi.org/10.1177/0885328216653287
Manzano, M., Ainaa, V., Areán, C.O., Balasa, F., Cauda, V., Colilla, M., Delgado, M.R., and Vallet-Regí, M., Chem. Eng. J., 2008, vol. 137, pp. 30–37. https://doi.org/10.1016/j.cej.2007.07.078
Wang, J.G., Li, F., Zhou, H.J., Sun, P.C., Ding, D.T., and Chen, T.H., Chem. Mater., 2009, vol. 21, pp. 612–620. https://doi.org/10.1021/cm803124a
Gao, C., Zheng, H., Xing, L., Shu, M., and Che, S., Chem. Mater., 2010, vol. 22, pp. 5437–5444. https://doi.org/10.1021/cm100667u
Cauda, V., Argyo, C., Schlossbauer, A., and Bein, T., J. Mater. Chem., 2010, vol. 20, pp. 4305–4311. https://doi.org/10.1039/B918590A
Szegedi, A., Popova, M., Goshev, I., and Mihály, J., J. Solid State Chem., 2011, vol. 184, pp. 1201–1207. https://doi.org/10.1016/j.jssc.2011.03.005
Szegedi, A., Popova, M., Goshev, I., Klébert, S., and Mihály, J., J. Solid State Chem., 2012, vol. 194, pp. 257–263. https://doi.org/10.1016/j.jssc.2012.05.030
Bahrami, Z., Badiei, A., and Atyabi, F., Chem. Eng. Res. Des., 2014, vol. 92, pp. 1296–1303. https://doi.org/10.1016/j.cherd.2013.11.007
Rehman, F., Ahmed, K., Airoldi, C., Gaisford, S., Buanz, A., Rahim, A., Muhammad, N., and Volpe, P.L.O., Mater. Sci. Eng., vol. 72, pp. 34–41. https://doi.org/10.1016/j.msec.2016.11.040
He, Y., Luo, L., Liang, S., Long, M., and Xu, H., J. Biomater. Appl., 2017, vol. 32, pp. 524–532. https://doi.org/10.1177/0885328217724638
Xu, P., Wang, H., Tong, R., Du, Q., and Zhong, W., Colloid Polym. Sci., 2006, vol. 284, pp. 755–762. https://doi.org/10.1007/s00396-005-1428-9
Eckstein, F., Antisense Nucleic Acid Drug Dev., 2009, vol. 10, pp. 117–121. https://doi.org/10.1089/oli.1.2000.10.117
Chelobanov, B.P., Burakova, E.A., Prokhorova, D.V., Fokina, A.A., and Stetsenko, D.A., Russ. J. Bioorg. Chem., 2017, vol. 43, pp. 664–668. https://doi.org/10.1134/S1068162017060024
Matano, Y., Ohkubo, H., Honsho, Y., Saito, A., Seki, S., and Imahori, H., Org. Lett., 2013, vol. 15, pp. 932–935. https://doi.org/10.1021/ol4000982
Nikolaev, V.A., Chiba, J., Tomohiro, T., and Hatanaka, Y., Encycl. Reagents Org. Synth., 2015. https://doi.org/10.1002/047084289X.rm069.pub2
Stöber, W., Fink, A., and Bohn, E., J. Colloid Interface Sci., 1968, vol. 26, pp. 62–69. https://doi.org/10.1016/0021-9797(68)90272-5
Atherton, E., Sheppard, R.C., and Ward, P., J. Chem. Soc. Perkin Trans., 1985, vol. 10, pp. 2065–2073. https://doi.org/10.1039/P19850002065
Prokhorova, D.V., Chelobanov, B.P., Burakova, E.A., Fokina, A.A., and Stetsenko, D.A., Russ. J. Bioorg. Chem., 2017, vol. 43, pp. 38–42. https://doi.org/10.1134/S1068162017010071
ACKNOWLEDGMENTS
Authors thank Dr. Е.А. Zelentsova (The Centre for Collective Use for Mass Spectroscopy Studies of the International Tomographic Centre, Siberian Branch of the Russian Academy of Sciences) for MALDI-TOF spectra of oligonucleotides.
Funding
The work was funded by Russian Foundation for Basic Research (grant no. 18-515-05007), and the Ministry of High Education and Science of the Russian Federation (project of Novosibirsk State University FSUS-2020-0035).
Author information
Authors and Affiliations
Contributions
А.V. Akobyan and Е.А. Burakova contributed equally to the work.
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This work contains no description of studies carried out by any of the authors that involve humans or animals.
Conflict of Interests
Authors declare no conflict of interests.
Additional information
Abbreviations: APTES, 3-aminopropyltriethoxysilane; СТАВ, cetyltrimethylammonium bromide; DMTr, 4,4'-dimethoxytrityl; MALDI-TOF, matrix assisted laser desorption ionization time of flight mass spectrometry; TCID50, median tissue culture infection dose; TEAA, triethylammonium acetate; АSF, African swine fever. All oligonucleotide sequences are 5'–3'; prefix d in oligodeoxyribonucleotides is omitted.
Corresponding author: phopne: +7 (383) 363-49-63.
Rights and permissions
About this article
Cite this article
Hakobyan, A.V., Burakova, E.A., Arabyan, E.A. et al. Antiviral Activity of Nanocomplexes of Antisense Oligonucleotides Targeting VP72 Protein in Vero Cells Infected by African Swine Fever Virus. Russ J Bioorg Chem 47, 411–419 (2021). https://doi.org/10.1134/S1068162021020035
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162021020035